A monocentric, retrospective study evaluating fruquintinib in mCRC patients who have previously failed with bevacizumab therapy
Latest Information Update: 19 Jul 2021
At a glance
- Drugs Fruquintinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology